Your session is about to expire
← Back to Search
Medical Food
Hepaxa for Non-alcoholic Fatty Liver Disease
N/A
Waitlist Available
Led By Reed Hogan, MD
Research Sponsored by BASF AS
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Men or women, ≥18 years of age.
Suspicion of NAFLD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This study measures the steatosis in patients With fatty livers as determined by CAP score from a fibroscan assessment. The study attempts to determine the effect of using the Medical Food Hepaxa in a Clinical setting Close to real-world use.
Eligible Conditions
- Non-alcoholic Fatty Liver Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The change in liver fat content (hepatic steatosis) from baseline to end of study
Secondary outcome measures
Change in Level of plasma triglycerides from baseline to end of study
Change in liver function test: aspartate aminotransferase (AST) from baseline (IU/L) to end of study
Change in the liver function test: alanine aminotransferase (ALT) from baseline (IU/L) to end of study
+2 moreOther outcome measures
Exploratory outcome. Stratification of effect Hepaxa using FLI score
Trial Design
1Treatment groups
Experimental Treatment
Group I: HepaxaExperimental Treatment1 Intervention
Subjects will receive Hepaxa according to standard use (4 capsules daily over a 6 month period)
Find a Location
Who is running the clinical trial?
BASF ASLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
Reed Hogan, MDPrincipal InvestigatorGI Associates and Endoscopy Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger